Projects per year
Personal profile
External positions
Member EAN scientific panel, European Academy of Neurology
18 Nov 2021 → …
Expert member SAG Neurology, European Medicines Agency
1 Aug 2021 → …
PhD, Neuroimmunology Unit, Division of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
1998 → 2001
Keywords
- R Medicine (General)
- Neurology
- Neuro-oncology
- AYA (Adolescents and Young Adults) with cancer
- RM Therapeutics. Pharmacology
- Clinical pharmacology
- Treatment Efficacy
- Toxicity
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
GLIOCARE
Keil, V., Wamelink, I., Azizova, A., Barkhof, F., Mutsaerts, H., Petr, J., de Witt Hamer, P., Wesseling, P. & Kouwenhoven, M.
1/04/2022 → …
Project: Research
-
SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT
Grun, N., den Otter, C. A., Sintemaartensdijk, M., Osinga, J., van den Elzen, F. E. L., van der Vegt, A. N., de Haan, J., Bruynzeel, A. M. E., van Linde, M. E., Postma, T. J., Schuur, M., Hamer, P. C. D. W., De Vos, F. Y. F. L., Verhoeff, J. J. C., Jongen, J. L. M., Lissenberg-Witte, B. I. & Kouwenhoven, M. C. M., Sept 2021, In: Neuro-oncology. 23, p. 40-40Research output: Contribution to journal › Meeting Abstract › Academic
-
ABSENCE OF SEVERE HEMATOLOGICAL TOXICITY DURING FIRST LINE TREATMENT PREDICTS LOW CHANCE ON SEVERE TOXICITY DURING SECOND LINE ALKYLATING CHEMOTHERAPY IN GLIOBLASTOMA
van den Elzen, F. E. L., Grun, N., Osinga, J., van der Vegt, A. N., de Glopper, L., Sintemaartensdijk, M., van Linde, M. E., Postma, T. J., Schuur, M. & Kouwenhoven, M. C. M., Sept 2021, In: Neuro-oncology. 23, p. 8-8Research output: Contribution to journal › Meeting Abstract › Academic
-
Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study
Gavioli, C., Vlooswijk, C., Janssen, S. H. M., Kaal, S. E. J., Kerst, J. M., Tromp, J. M., Bos, M. E. M. M., van der Hulle, T., van der Graaf, W. T. A., Lalisang, R. I., Nuver, J., Bijlsma, R. M., Kouwenhoven, M. C. M., Husson, O. & Beijer, S., 2024, (E-pub ahead of print) In: Journal of Cancer Survivorship.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions
Küçükosmanoglu, A., Scoarta, S., Houweling, M., Spinu, N., Wijnands, T., Geerdink, N., Meskers, C., Kanev, G. K., Kiewiet, B., Kouwenhoven, M., Noske, D., Wurdinger, T., Pouwer, M., Wolff, M. & Westerman, B. A., 15 Apr 2024, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 30, 8, p. 1685-1695 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Exploring the interconnectedness between health-related quality of life factors among long-term adolescent and young adult cancer survivors (AYAs): a network analysis
Bootsma, T. I., van de Wal, D., Vlooswijk, C., Roos, D. C., Drabbe, C., Tissier, R., Bijlsma, R. M., Kaal, S. E. J., Kerst, J. M., Tromp, J. M., Bos, M. E. M. M., van der Hulle, T., Lalisang, R. I., Nuver, J., Kouwenhoven, M. C. M., van der Graaf, W. T. A., Janssen, S. H. M. & Husson, O., 1 Feb 2024, In: Supportive Care in Cancer. 32, 2, p. 104 104.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
-
European Medicines Agency (External organisation)
Mathilde Kouwenhoven (Chair)
24 May 2021 → …Activity: Membership › Membership of committee › Academic
-
Prognostication and surgical management of diffuse gliomas in the era of molecular diagnostics
Mathilde Kouwenhoven (Examiner)
28 May 2019Activity: PhD thesis Examination › Examination › Educational
-
Het incidentaloom, bijvangst van de moderne geneeskunde.
Mathilde Kouwenhoven (Speaker)
15 Mar 2019Activity: Lecture / Presentation › Invited talk › Academic
-
Landelijke Werkgroep Neuro-oncologie (External organisation)
Mathilde Kouwenhoven (Chair)
2018 → …Activity: Membership › Membership of committee › Academic
-
American Academy of Neurology (External organisation)
Mathilde Kouwenhoven (Chair)
2018 → …Activity: Membership › Membership of network › Professional